AST Funding: How Much Did They Raise & Key Investors

How Much Did AST Raise?
Funding & Key Investors

AST, a provider of advanced aseptic filling and closing systems for the pharmaceutical and biotechnology sectors, has secured $350K in total funding, with its most recent capital infusion amounting to $350K from a major strategic investment on May 3, 2020. This significant backing underscores the company's established position in a critical segment of the life sciences supply chain.

What is AST?

AST

Manufacturing

Industrial Machinery & Equipment

AST specializes in delivering innovative and flexible aseptic filling and closing systems tailored for the demanding pharmaceutical and biotechnology industries. Leveraging decades of expertise, the company's solutions are engineered to adhere to stringent product and regulatory requirements. Their comprehensive offerings include integrated fill-finish systems, advanced aseptic processing solutions, and a variety of container filling technologies, serving clients across drug development, biologics manufacturing, cell and gene therapy, and compounding pharmacies.

How much funding has AST raised?

AST has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in AST

PPP

Public-Private Partnership

What's next for AST?

The substantial late-stage funding context suggests AST is poised for significant expansion and further technological development. This strategic investment will likely fuel enhancements in manufacturing capacity, research and development for next-generation aseptic processing, and broader market penetration. AST's focus on critical areas like cell and gene therapy positions it to capitalize on emerging trends in personalized medicine, with this capital injection enabling accelerated growth and reinforced market leadership.

See full AST company page

See More Financial Insights